{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:10:34Z","timestamp":1765354234886},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.amjopharm.2011.02.002","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T20:07:36Z","timestamp":1301688456000},"page":"88-92","source":"Crossref","is-referenced-by-count":20,"title":["Linezolid-Associated Hypoglycemia in a 64-Year-Old Man With Type 2 Diabetes"],"prefix":"10.1016","volume":"9","author":[{"given":"Timothy","family":"Bodnar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey B.","family":"Halter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2011.02.002_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2008\/846453","article-title":"Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care","volume":"19","author":"Ki","year":"2008","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"Suppl 5","key":"10.1016\/j.amjopharm.2011.02.002_bib2","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1086\/533593","article-title":"Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus","volume":"46","author":"Stryjewski","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib3","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1128\/AAC.50.4.1599-1602.2006","article-title":"Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: A proposed protocol for monitoring therapy in complex patients","volume":"50","author":"Bishop","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMoa055191","article-title":"Outpatient gatifloxacin therapy and dysglycemia in older adults","volume":"354","author":"Park-Wyllie","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.0306-5251.2001.01456.x-i2","article-title":"Possible interaction between gliclazide, fluconazole, and sulfamethoxazole resulting in severe hypoglycaemia","volume":"52","author":"Abad","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib7","series-title":"Linezolid (Zyvox) [package insert]","year":"2006"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(66)91399-7","article-title":"Potentiation of insulin hypoglycaemia by M.A.O.I. antidepressant drugs","volume":"1","author":"Cooper","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2337\/diab.17.10.628","article-title":"Hypoglycemic action of monoamineoxidase inhibitors (MAOI's)","volume":"17","author":"Adnitt","year":"1968","journal-title":"Diabetes"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0026-0495(75)90138-9","article-title":"Characterization of pancreatic islet monoamine oxidase","volume":"24","author":"Feldman","year":"1976","journal-title":"Metabolism"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/j.1552-4604.1994.tb03969.x","article-title":"Hypoglycemia caused by selegiline, an antiParkinson drug: Can such side effects be predicted?","volume":"34","author":"Rowland","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/dc09-2009","article-title":"Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes","volume":"33","author":"Gaziano","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1179\/joc.2010.22.1.17","article-title":"Linezolid penetration into cerebrospinal fluid and brain tissue","volume":"22","author":"Tsona","year":"2010","journal-title":"J Chemother"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.02.002_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/380449","article-title":"Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillin-clavulanate","volume":"38","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T12:23:06Z","timestamp":1560082986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594611000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1543594611000067"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2011.02.002","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}